FDA Approved: VORICONAZOLE — Supplemental Application (Xellia Pharmaceuticals USA LLC)

View source ↗

Summary

FDA approved a supplemental application for Voriconazole by Xellia Pharmaceuticals USA LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Candidiasis
• Esophageal Candidiasis
• Invasive Aspergillosis

Drugs mentioned

• VORICONAZOLE (Voriconazole)

Snippet

SUPPL AP for VORICONAZOLE (VORICONAZOLE)